15 results on '"Viala, Jérôme"'
Search Results
2. Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn's disease: A retrospective multicenter cohort study of the "GETAID pédiatrique".
3. Jejunal Feeding by Gastrojejunal Tube in Pediatric Refractory Gastroesophageal Reflux Disease.
4. Endoscopic Balloon Dilatation in Pediatric Crohn Disease: An IBD Porto Group Study.
5. Ustekinumab Use in Pediatric Inflammatory Bowel Disease: A French Multicenter Study From the Pediatric GETAID.
6. Clinical Remission and Psychological Management are Major Issues for the Quality of Life in Pediatric Crohn Disease.
7. Trough Levels of Infliximab at Week 6 Are Predictive of Remission at Week 14 in Pediatric Crohn's Disease.
8. Efficacy and Safety of the Local Application of Mitomycin C to Recurrent Esophageal Strictures in Children.
9. Tacrolimus Exerts Only a Transient Effectiveness in Refractory Pediatric Crohn Disease: A Case Series.
10. Postsurgical Perforation of the Esophagus Can Be Treated Using a Fully Covered Stent in Children.
11. Paediatric Gastrointestinal Endoscopy: European Society for Paediatric Gastroenterology Hepatology and Nutrition and European Society of Gastrointestinal Endoscopy Guidelines.
12. Biopsy-Induced Duodenal Hematoma Is Not an Infrequent Complication Favored by Bone Marrow Transplantation.
13. Plummer-Vinson Syndrome in Children.
14. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin.
15. EP32. Trough levels to Infliximab at W6 are predictive of remission at W14, in pediatric Crohn's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.